Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Felthaus

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|February 7, 2009
Strong inducible knockdown of APC/CCdc20 does not cause mitotic arrest in human somatic cellsAxel J Baumgarten, Julia Felthaus, Ralph Wäsch
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2024
Targeting Mitotic Exit in Malignant CellsChristine Greil, Monika Engelhardt, Julia Felthaus, et al.
Plos One|September 24, 2013
The 3' untranslated region of the cyclin B mRNA is not sufficient to enhance the synthesis of cyclin B during a mitotic block in human cellsDominik Schnerch, Marie Follo, Julia Felthaus, et al.
Journal of Visualized Experiments : Jove|September 26, 2012
Studying proteolysis of cyclin B at the single cell level in whole cell populationsDominik Schnerch, Marie Follo, Julia Felthaus, et al.
Cell Cycle (Georgetown, Tex.)|January 5, 2012
Monitoring APC/C activity in the presence of chromosomal misalignment in unperturbed cell populationsDominik Schnerch, Marie Follo, Julika Krohs, et al.
Haematologica|July 2, 2013
BubR1 is frequently repressed in acute myeloid leukemia and its re-expression sensitizes cells to antimitotic therapyDominik Schnerch, Andrea Schmidts, Marie Follo, et al.
Leukemia & Lymphoma|June 29, 2010
Monitoring bortezomib therapy in multiple myeloma: screening of cyclin D1, D2, and D3 via reliable real-time polymerase chain reaction and association with clinico-pathological features and outcomeBa Thanh-Truc Ngo, Julia Felthaus, Manuel Hein, et al.
Leukemia & Lymphoma|October 22, 2013
Up-regulation of RUNX2 in acute myeloid leukemia in a patient with an inherent RUNX2 haploinsufficiency and cleidocranial dysplasiaDominik Schnerch, Ekkehart Lausch, Heiko Becker, et al.
Oncotarget|April 19, 2017
Proteasome inhibition enhances the efficacy of volasertib-induced mitotic arrest in AML in vitro and prolongs survival in vivoDominik Schnerch, Julia Schüler, Marie Follo, et al.
American Journal of Cancer Research|August 6, 2021
Targeting mitotic exit in solid tumorsChristine Greil, Julia Felthaus, Marie Follo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|February 7, 2009
Strong inducible knockdown of APC/CCdc20 does not cause mitotic arrest in human somatic cellsAxel J Baumgarten, Julia Felthaus, Ralph Wäsch
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2024
Targeting Mitotic Exit in Malignant CellsChristine Greil, Monika Engelhardt, Julia Felthaus, et al.
Plos One|September 24, 2013
The 3' untranslated region of the cyclin B mRNA is not sufficient to enhance the synthesis of cyclin B during a mitotic block in human cellsDominik Schnerch, Marie Follo, Julia Felthaus, et al.
Journal of Visualized Experiments : Jove|September 26, 2012
Studying proteolysis of cyclin B at the single cell level in whole cell populationsDominik Schnerch, Marie Follo, Julia Felthaus, et al.
Cell Cycle (Georgetown, Tex.)|January 5, 2012
Monitoring APC/C activity in the presence of chromosomal misalignment in unperturbed cell populationsDominik Schnerch, Marie Follo, Julika Krohs, et al.
Haematologica|July 2, 2013
BubR1 is frequently repressed in acute myeloid leukemia and its re-expression sensitizes cells to antimitotic therapyDominik Schnerch, Andrea Schmidts, Marie Follo, et al.
Leukemia & Lymphoma|June 29, 2010
Monitoring bortezomib therapy in multiple myeloma: screening of cyclin D1, D2, and D3 via reliable real-time polymerase chain reaction and association with clinico-pathological features and outcomeBa Thanh-Truc Ngo, Julia Felthaus, Manuel Hein, et al.
Leukemia & Lymphoma|October 22, 2013
Up-regulation of RUNX2 in acute myeloid leukemia in a patient with an inherent RUNX2 haploinsufficiency and cleidocranial dysplasiaDominik Schnerch, Ekkehart Lausch, Heiko Becker, et al.
Oncotarget|April 19, 2017
Proteasome inhibition enhances the efficacy of volasertib-induced mitotic arrest in AML in vitro and prolongs survival in vivoDominik Schnerch, Julia Schüler, Marie Follo, et al.
American Journal of Cancer Research|August 6, 2021
Targeting mitotic exit in solid tumorsChristine Greil, Julia Felthaus, Marie Follo, et al.
Pageof 2